Russian Pharmaceutical Industry Leader

Products

Kemeruvir®
Pharmacotherapeutic group
Antiviral for the treatment of HIV infections
International name
Darunavir
Dosage form
Tablets
Description Manufacturer Pharmacies Leave a feedback
Antiviral drug, HIV-1 protease inhibitor. Darunavir, the active ingredient, inhibits dimerization and catalytic activity of HIV-1 protease. It selectively inhibits cleavage of the HIV Gag-Pol polyproteins in infected cells, thereby preventing formation of mature viral particles. Darunavir has a high barrier to mutations inducing drug-resistance to protease inhibitors. It does not inhibit any of 13 tested human cellular proteases.
Send
NAME AND SURNAME*
E-mail
Subject*
Message*
Captcha*
* — Required field